Alemtuzumab, a monoclonal antibody used in the treatment of certain types of leukemia, represents a significant advancement in cancer therapy. The development of the Alemtuzumab ELISA (Enzyme-Linked Immunosorbent Assay) kit has further enhanced the application and effectiveness of this therapeutic agent. This assay is crucial for accurately measuring the concentration of Alemtuzumab in patient...